TrialSignal
Clinical trial intelligence report
Feasibility, Acceptability, and Safety of Neonatal Male Circumcision at the University Teaching Hospital in Lusaka, Zambia and in the Lusaka District in Zambia Using Gomco; Plastibell; and Mogen Methods
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT01115335
Status
COMPLETED
Phase
Phase 4
Sponsor
University of Alabama at Birmingham
Executive brief
Investment-Ready Snapshot
This study evaluates the feasibility, acceptability, and safety of neonatal male circumcision (NMC) in Lusaka, Zambia, using three surgical methods: Gomco, Plastibell, and Mogen. The research aims to inform the scale-up of NMC services as part of Zambia's HIV prevention strategy.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT01115335
Indication
Neonatal Male Circumcision
Modality
medical device
Target
Neonatal Male Circumcision
Intervention
Neonatal male circumcision
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.